Stanniocalcin 1 (STC1) Expression as a Predictor of Late Breast Cancer Recurrence: Evaluating STC1 in Recurrent Tumors Pubblico

Abstract

Background:Expression of the Stanniocalcin 1 (STC1) hormone is associated with increased cancer risk and progression, and may increase the likelihood of recurrence. We investigate the hypothesis that STC1 expression is higher in recurrent tumors of patients experiencing late recurrence compared to early recurrence. 

Methods:A total of 194 estrogen receptor-positive, tamoxifen-treated (ER⁺/TAM⁺) and 116 estrogen receptor-negative, tamoxifen-untreated (ER^-/TAM^-) breast cancer recurrence patients who experienced recurrence within 10 years post diagnosis were selected from a cohort of 11,251 Danish breast cancer patients diagnosed from 1985 to 2001. The association between IHC expression of STC1 in recurrent tumor tissues was evaluated within intervals of time to recurrence (2 to <3 years, 3 to <4 years, 4 to <6 years, 6 to <10 years, ref: 1 to <2 years).

Results:Dichotomized STC1 expression (positive /negative) was not associated with recurrence at any time interval including late recurrence, 6 to 10 years (aOR = 0.43; 95% CI, 0.1-1.74).

Conclusion:Our results do not suggest an association between recurrent tumor STC1 expression and breast cancer recurrence. While the evidence is insufficient to draw conclusions, there was a trend of decreasing odds of recurrence over increasing time to event intervals that may suggest that STC1 expression in the primary tumor may be important to potentiate late recurrence, but not necessary to maintain that potential.

Table of Contents

CHAPTER I: Background/Literature Review 1

CHAPTER II: Manuscript 4

Introduction 5

Methods 6

Results 9

Discussion 10

References 13

Tables 16

CHAPTER III: Summary, Public Health Implications, Possible Future Directions 19

About this Master's Thesis

Rights statement

• Permission granted by the author to include this thesis or dissertation in this repository. All rights reserved by the author. Please contact the author for information regarding the reproduction and use of this thesis or dissertation.

School	Rollins School of Public Health
Department	Epidemiology
Subfield / Discipline	Global Epidemiology - MPH & MSPH
Degree	M.P.H.
Submission	Master's Thesis
Language	English
Research Field	Health Sciences, Epidemiology Biology, Molecular
Parola chiave	STC1 Stanniocalcin 1 recurrent tumor breast cancer breast cancer recurrence late recurrence
Committee Chair / Thesis Advisor	Lash, Timothy, Emory University

Ultima modifica

Primary PDF

Thumbnail	Title	Date Uploaded	Actions
	Stanniocalcin 1 (STC1) Expression as a Predictor of Late Breast Cancer Recurrence: Evaluating STC1 in Recurrent Tumors ()	2019-04-24 14:07:46 -0400	Press to Select an action Download

Supplemental Files

Thumbnail	Title	Date Uploaded	Actions